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Introduction 
Gestational trophoblastic disease (GTD) represents a 
spectrum of interrelated placental trophoblastic 
lesions, which can be further classified into benign 
and malignant [1, 2]. Epithelioid trophoblastic tumor 
(ETT), first described in 1998 [3], is the most recent 
addition to GTD. With approximately 100 cases 
reported until recently [4], it is a form of GTD arising 
from chorionic-type intermediate trophoblastic cells 
[2, 5]. Although metastasis is known to occur in ETT, 
cutaneous metastases have not been previously 
reported. We present the case of a reproductive-
aged woman with an undiagnosed ETT, first 
manifesting with keratoacanthoma-like cutaneous 
metastases. 
 
Case Synopsis 
A 40-year-old woman, with no relevant medical 
history, presented with multiple nodules on the 
scalp. The patient stated the first lesion, in the right 
frontal region, appeared 8 months before and 
spontaneously regressed over two months. After 
that, several similar persistent nodules developed, 
scattered across the scalp; they had rapidly grown 
over a few weeks. 
On physical examination there were 10 firm, dome-
shaped, well-circumscribed nodules with central 
crateriform ulceration and hyperkeratotic cores, 
ranging in size from one to 6cm (Figure 1). Enlarged 
cervical lymphadenopathy was appreciated. The 
patient denied accompanying systemic 
symptomatology. 
A skin biopsy of one of the nodules revealed 
anastomosing cords and nests of atypical epithelioid 
cells with eosinophilic cytoplasm and large, 
pleomorphic nuclei (Figure 2). Immunohisto- 
Abstract 
Cutaneous metastases are rarely the initial 
manifestation of a previously undiagnosed 
malignancy and keratoacanthoma-like lesions are a 
notoriously unusual presentation pattern of 
cutaneous dissemination of a primary tumor. Herein, 
we report a 40-year-old woman presenting to our 
dermatology department with multiple 
keratoacanthoma-like scalp nodules. Subsequent 
investigation determined it to be the first 
manifestation of a disseminated endometrial 
epithelioid trophoblastic tumor, eventually causing 
the patient’s death. Epithelioid trophoblastic tumor, 
a rare form of gestational trophoblastic disease, is a 
recently described neoplasm whose cutaneous 
metastasis has not been previously reported in the 
literature. 
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chemical staining showed diffuse positivity for 
cytokeratin 5/6, 34BE12 and focal positivity for 
epithelial membrane antigen (EMA). In contrast to 
the clinical impression, the histological features of 
the lesions were not compatible with 
keratoacanthoma. The conclusion pointed to a 
fragment of poorly differentiated carcinoma; 
considering the multifocality of the lesions and the 
limited connection with the epidermis, the 
hypothesis of metastasis was favored. 
Within a few weeks the patient reported the onset of 
persistent cough, pain of the left shoulder and upper 
limb, intermittent vaginal bleeding, and the 
presence of a vulvar mass. The patient was then 
evaluated by the gynecology department. Previous 
reproductive history included a spontaneous 
abortion and 2 cesarean deliveries, the last one 9 
years before. On examination there was a solitary 
nodule on the inner side of the right labium majus, 
measuring 3cm in diameter and macroscopically 
similar to the lesions on the scalp. The biopsy of the 
vulvar nodule revealed morphological features 
identical to those of the scalp biopsy, but this time 
immunohistochemical staining identified positivity 
for beta-human chorionic gonadotropin (β-HCG), 
raising the possibility of metastasis of an epithelial 
malignant neoplasm producer of β-HCG. 
Subsequent imaging performed disclosed an 
irregular endometrial surface with an expansive 
tumor with irregular borders, locally infiltrating the 
myometrium. These findings pointed to a diagnosis 
of endometrial ETT. Serum level of β-HCG was 
determined, showing high levels (449mIU/mL) that 
gradually increased in subsequent evaluations (556, 
924, 1187mIU/mL). The workup included endoscopic 
studies showing an ulcerated tumor in the 
descending colon; biopsy revealed morphological 
findings similar to those of the other histological 
studies. Histological examinations of the cutaneous, 
vulvar, and intestinal material were reviewed and all 
lesions exhibited the same histopathological and 
immunohistochemical findings, consistent with the 
diagnosis of ETT. 
A battery of radiological studies was performed, 
revealing multiple systemic metastases: nodal, 
pulmonary, pleural, cardiac (left ventricular), hepatic, 
pancreatic, osseous, renal, intestinal, vaginal (labia 
majora), muscular, subcutaneous, and cutaneous. At 
Figure 1. A) Examination revealed well-circumscribed nodules 
resembling keratoacanthomas. B) Detail of one of the nodules, 
with central crateriform ulceration and hyperkeratotic core. 
Figure 2. Histologic examination revealed atypical epithelioid 
cells with eosinophilic cytoplasm and large and pleomorphic 
nuclei. H&E, 400×.
A 
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this point, the patient was diagnosed as having 
metastatic ETT. Multi-agent chemotherapy 
(etoposide, methotrexate, actinomycin D, 
cyclophosphamide, vincristine) was initiated but had 
to be suspended owing to medical complications. A 
palliative approach, with supportive care and 
palliative radiation therapy was advocated. 
However, the patient deteriorated rapidly and died 
approximately 7 months after first presenting to the 
dermatology department. 
 
Case Discussion 
Epithelioid trophoblastic tumor is an exceedingly 
rare tumor, seen mostly in reproductive-aged 
women [6]; it can be a sequel of any gestational 
event. Approximately one-third of cases arise 
following a spontaneous abortion or hydatidiform 
mole, whereas the majority occur after a full-term 
pregnancy [2, 5, 7]. The average interval from the 
antecedent gestational event to presentation varies, 
ranging from two months to as long as 18 years [2, 4, 
5]. Epithelioid trophoblastic tumor can present in 
both intrauterine and extrauterine sites [2, 6]. Most 
often the uterus is the primary site (40%), followed by 
the cervix (31%). The lung is the most common 
extrauterine site, accounting for 19% of cases [2]. The 
most common presentation is with abnormal vaginal 
bleeding, although the presentation in some cases 
relates to metastases in lung, vagina, or broad 
ligament [2, 5, 6, 8]. At the time of diagnosis, serum 
β-HCG levels are elevated but generally do not 
exceed 2500mIU/mL [2, 4-6, 8]. 
The diagnosis can usually be made on morphological 
grounds. In particular suspicion should be high 
because the patients are usually relatively young, 
have experienced a gestational event, and exhibit an 
elevated serum β-HCG [8]. Microscopically the tumor 
presents features resembling a poorly differentiated 
carcinoma. The neoplastic cells are small and 
epithelioid, with eosinophilic-to-clear cytoplasm. 
The cells are arranged in a monomorphic pattern of 
nests and cords, embedded in a hyaline matrix [4, 5, 
8]. Although the immunohistochemical staining 
patterns of the reported cases are not uniform [8], 
inhibin alfa, cytokeratin AE1/AE3, EMA, and other 
trophoblastic markers including β-HCG, human 
placental lactogen (HPL), and placental alkaline 
phosphatase are commonly expressed [2, 5]. 
Although ETT displays an unpredictable but usually 
benign and indolent behavior in most instances [1, 5, 
6], metastases and death occur in approximately 
25% and 10% of patients, respectively [6, 8]. 
Epithelioid trophoblastic tumor is relatively 
chemotherapy resistant and surgical resection is the 
primary treatment modality [2]. The differential 
diagnosis of ETT includes other forms of GTD 
(placental site nodule, exaggerated placental site 
reaction, placental site trophoblastic tumor, and 
choriocarcinoma), squamous cell carcinoma of the 
cervix, and epithelioid leiomyosarcoma [2, 6, 8]. 
Placental site trophoblastic tumor (PSTT) can be 
difficult to differentiate from ETT as these are both 
malignant neoplasms of subtypes of intermediate 
trophoblast [8]. Histologically, ETT is distinguished 
from PSTT by its smaller, more monomorphic cells 
and by its nested, nodular, well circumscribed 
growth pattern, unlike the sheet-like deeply 
infiltrative pattern and prominent vascular invasion 
seen with PSTT [6, 8, 9]. Relatively to ETT, PSTT cells 
display a characteristic immunostaining pattern, 
with a more diffusely positive staining for HPL and 
only focal staining for β-HCG [2, 6,9-11]. The 
morphological features, along with the scantly 
infiltrative pattern and the absence of staining for 
HPL, favored the diagnosis of ETT, as opposed to 
previously reported cases of scalp metastasis of PSTT 
[10, 11]. 
Cutaneous metastases are markers of a poor 
prognosis, correlating with disease progression and 
a median survival time after their presentation of 
approximately 3-6 months [12-14]. Clinical 
presentation of cutaneous metastases is variable. 
Typically manifesting as dermal and subcutaneous 
papules and nodules, they can also mimic 
dermatologic conditions such as alopecia, cutaneous 
horn, cysts, dermatitis, bacterial (such as erysipelas 
and acute paronychia) and viral (such as zosteriform 
lesions) infections, or vascular lesions (such as 
pyogenic granuloma). Keratoacanthoma-like lesions 
are much more rare [14-16]. 
The most common metastatic sites for GTD are the 
lungs, liver, and brain. Gestational trophoblastic 
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disease with skin metastases has been reported but 
is exceedingly rare [17, 18]. It is reported that ETT can 
metastasize to the lung as well as to the brain, liver, 
abdominal cavity, vagina, tonsil, and lymph nodes [6, 
8]. However, to the best of our knowledge, there are 
no previous reports of ETT with cutaneous 
metastases. 
Cutaneous metastases of internal malignancies with 
keratoacanthomalike morphology are extremely 
rare [14], with fewer than 20 cases reported until now 
[12]. Lung, larynx, breast, esophagus, bronchus and 
renal cancer, mesothelioma, angiosarcoma, 
chondrosarcoma, anaplastic large cell lymphoma, 
and malignant melanoma are the primary 
malignancies accounting for the majority of these 
reports [12-14,19]. In the reported cases, 
keratoacanthoma-like cutaneous metastases tend to 
have a biologic behavior and appearance similar to 
that of an idiopathic keratoacanthoma: a solitary, 
asymptomatic, rapidly growing, firm, dome-shaped 
nodule with a central keratin-filled crater that grows 
rapidly in 4-to-6 weeks and spontaneously involutes 
within 6 months [15]. When multiple, the lesions 
should also be differentiated from previously known 
conditions of multiple keratoacanthomas, such as 
Muir-Torre syndrome, generalized eruptive 
keratoacanthomas of Grzybowski, and Ferguson-
Smith type multiple keratoacanthomas [14]. 
Keratoacanthoma-like cutaneous metastases tend to 
appear in the course of a previously diagnosed 
internal malignancy rather than be the first sign of 
the disease [13]. The histological findings observed 
in keratoacanthoma-like metastatic lesions are 
generally similar to those in the primary site tumor 
[12, 14, 15]. 
 
Conclusion 
In summary, we present a patient with metastatic 
ETT, a rare primary tumor whose usual first 
manifestation is abnormal vaginal bleeding. 
However, our patient presented with multiple 
cutaneous metastases. Although vaginal and colonic 
metastases have been previously described [8], to 
the best of our knowledge this is the first report of 
ETT with cutaneous metastases. The morphologic 
pattern of keratoacanthoma-like metastases is also 
notable. The spontaneous regression of the first 
lesion the patient reported is consistent with the 
expectable evolution of the lesions, similar to 
idiopathic keratoacanthomas. However, the 
disseminated metastases, including the uncommon 
left ventricular tumors, are remarkable since ETT is 
considered a relatively indolent tumor. Although 
rarely encountered, multiple keratoacanthoma-like 
nodules should raise the possibility of cutaneous 
metastases of an internal malignancy. 
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